http://www.immunepharma.com/wp-content/uploads/2017/03/NK_AAD-17-Emerging-Rx-for-Goid.pdf http://www.immunepharma.com/news-events/ http://www.immunepharma.com/preliminary-data-with-bertilimumab-in-an-open-label-phase-2a-study-in-the-rare-dermatological-auto-immune-disease-bullous-pemphigoid-presented-at-the-american-academy-of-dermatology-2017-annual-meet/